GlucoTrack, Inc. of RUTHERFORD, NJ, a company, filed a Form D amendment with the SEC on 2013-03-28. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Other Health Care.
Showing 25 of 38 people.
| Name | Role | Location |
|---|---|---|
| Israel L Ehrlich | Director | Ashkelon, L3 |
| Joel L Gold | Director | Ashkelon, L3 |
| Jacob L Bar-Shalom | Executive Officer | Ashkelon, L3 |
| Philip Darivoff | Director | New York, NY |
| James Cardwell | Executive Officer | SAINT-SAUVEUR, A8 |
| JOHN GRAHAM | Director | BELLEVUE, WA |
| JOHN GRAHAM | Executive Officer | BELLEVUE, WA |
| Angela Strand | Director | San Diego, CA |
| Angela Strand | Executive Officer | San Diego, CA |
| Paul Goode | Executive Officer | Rutherford, NJ |
| Shimon Rapps | Director | Rutherford, NJ |
| Andrew Sycoff | Director | Rutherford, NJ |
| Erin Carter | Director | Rutherford, NJ |
| Luis Malave | Director | Rutherford, NJ |
| Allen Danzig | Director | Rutherford, NJ |
| Robert Fischell | Director | Rutherford, NJ |
| David Malka | Director | San Juan, PR |
| David Malka | Executive Officer | San Juan, PR |
| Revan Schwartz | Director | Ashod, L3 |
| Jolie Kahn | Executive Officer | Ashod, L3 |
| Sami Sassoun | Executive Officer | Ashdod, L3 |
| Michael Hauck | Director | Ashdod, L3 |
| David Podwalski | Executive Officer | Ashdod, L3 |
| Eugene Naidis | Director | Ashdod, L3 |
| Eugene Naidis | Executive Officer | Ashdod, L3 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-05-08 | D | $500K | $500K |
| 2020-02-28 | D | $15.0M | $15.0M |
| 2017-12-11 | D | $10.0M | $425K |
| 2017-06-28 | D/A | $12.0M | $11.0M |
| 2017-01-20 | D/A | $12.0M | $6.2M |
| 2016-04-18 | D | $12.0M | $1.1M |
| 2014-09-12 | D | $8.5M | $3.0M |
| 2012-12-03 | D | $5.5M | $1.2M |
| 2010-12-27 | D | $12.5M | $3.6M |